Yaldizli, Ö. and Benkert, P. and Maceski, A. and Barakovic, M. and Todea, R.-A. and Cagol, A. and Schaedelin, S. and Disanto, G. and Oechtering, J. and Orleth, A. and Rey, D. and Sinnecker, T. and Rahmanzadeh, R. and Zadic, S. and Galbusera, R. and Achtnichts, L. and Aeschbacher, S. and Chan, A. and Conen, D. and Derfuss, T. and Findling, O. and Fischer-Barnicol, B. and Hrusovsky, K. and Kropshofer, H. and Lalive, P. and Lieb, J. and Lorscheider, J. and Maggi, P. and Mueller, C. and Mueller, S. and Naegelin, Y. and Mueller, J. and Oksenberg, J. and Pot, C. and Du Pasquier, R. and Radue, E.-W. and Salmen, A. and Vehoff, J. and Waubant, E. and Wellmann, S. and Wiendl, H. and Wuerfel, J. and Zecca, C. and Berger, K. and Gobbi, C. and Kappos, L. and Leppert, D. and Granziera, C. and Kuhle, J.
(2020)
Value of serum neurofilament light chain levels as a biomarker of suboptimal treatment response in MS clinical practice.
In: 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), SEP 11-13, 2020, Virtuell.
Full text not available from this repository.
Actions (login required)
 |
View Item |
